Tag: today-announced

Lion Biotechnologies Announces Publication of Data From Clinical Study of Metastatic Cervical Cancer Patients Treated …

| April 8, 2015 | 0 Comments

LOS ANGELES — Lion Biotechnologies, Inc. , a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced that data from a metastatic …

Continue Reading

Blueprint Medicines to Present New Preclinical Data on BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug …

| April 8, 2015 | 0 Comments

CAMBRIDGE, Mass., April 8, 2015 /PRNewswire/ —

Continue Reading

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

| April 6, 2015 | 0 Comments

Amgen today announced that the European Commission approved a new use of Vectibix (panitumumab) as first-line treatment in combination with FOLFIRI for the treatment of adult patients with wild-type (WT) RAS metastatic colorectal cancer (mCRC).

Continue Reading

European Commission Approves Amgen's Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLFIRI …

| April 6, 2015 | 0 Comments

THOUSAND OAKS, Calif., April 6, 2015 /PRNewswire/ — Amgen (AMGN) today announced that the European Commission approved a new use of Vectibix® (panitumumab) as first-line treatment in combination with FOLFIRI for the treatment of adult patients with wild-type (WT) RAS metastatic colorectal cancer (mCRC). About half of the patients with mCRC have WT RAS tumors.1  FOLFIRI, an irinotecan-based …

Continue Reading

Astellas Pharma, MD Anderson sign option agreement to research and develop new treatment for AML

| April 6, 2015 | 0 Comments

Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center today announced the signing of an option agreement to research and develop a new treatment for patients with acute myeloid leukemia (AML).

Continue Reading

ADAO Applauds U.S. Surgeon General for Statement on the Dangers of Asbestos in Support of National Asbestos Awareness …

| April 2, 2015 | 0 Comments

The Asbestos Disease Awareness Organization , which combines education, advocacy, and community to prevent exposure and ensure justice for asbestos victims, today announced its strong support for the statement from Vice Admiral Vivek H.

Continue Reading

Cancer Genetics, Inc. Increases Access to Its Comprehensive Cancer Diagnostic Tests & Services Through Agreement With …

| April 1, 2015 | 0 Comments

RUTHERFORD, N.J. — Cancer Genetics, Inc. (“CGI” or “the Company”), an emerging leader in DNA-based cancer diagnostics, today announced that it has executed an agreement with America's …

Continue Reading

FDA Grants Amgen Priority Review for Kyprolis® (Carfilzomib) Supplemental New Drug Application for the Treatment of …

| March 30, 2015 | 0 Comments

THOUSAND OAKS, Calif., March 30, 2015 /PRNewswire/ — Amgen (AMGN) today announced that the U.S.

Continue Reading

Asbestos Disease Awareness Organization (ADAO) Announces Unity and Remembrance Brunch Sunday, April 19

| March 30, 2015 | 0 Comments

The Asbestos Disease Awareness Organization , which combines education, advocacy, and community to prevent exposure and ensure justice for asbestos victims, today announced t

Continue Reading

Leading UK charity selects Storage Made Easy Enterprise File Sync and Share to securely work with file content

| March 27, 2015 | 0 Comments

LONDON, March 27, 2015 /PRNewswire/ — Storage Made Easy today announced that the UK based charity, The Bone Cancer Research Trust, was using its Enterprise File Sync and Share software solution. The Bone Cancer Research Trust (BCRT) is a charity in the UK and Ireland dedicated…

Continue Reading